STAGE II LUNG CANCER AJCC V8
Clinical trials for STAGE II LUNG CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE II LUNG CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE II LUNG CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Proton beam therapy doses tested for inoperable lung cancer
Disease control CompletedThis study looked at people with stage 2 or 3 non-small cell lung cancer that could not be removed by surgery. They received standard chemotherapy along with different doses of proton beam radiation to find the safest and most effective dose. The goal was to see if higher doses h…
Matched conditions: STAGE II LUNG CANCER AJCC V8
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Apr 29, 2026 01:49 UTC
-
Immunotherapy drug shows promise in preventing lung cancer recurrence
Prevention CompletedThis study tested whether the immunotherapy drug pembrolizumab could help prevent lung cancer from coming back in people with early-stage non-small cell lung cancer or high-risk lung nodules. Forty-five participants received the drug, and researchers tracked tumor response and su…
Matched conditions: STAGE II LUNG CANCER AJCC V8
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Prevention
Last updated Apr 29, 2026 01:49 UTC
-
Tiny heart monitor spies hidden damage during cancer radiation
Knowledge-focused CompletedThis study looked at how radiation treatment for lung or esophageal cancer affects the heart. 24 patients received a small implanted heart monitor to track changes that might otherwise go unnoticed. The goal was to find early signs of heart problems so they can be treated sooner …
Matched conditions: STAGE II LUNG CANCER AJCC V8
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Apr 29, 2026 01:50 UTC